Intended for healthcare professionals

Editor's Choice

New uses for existing treatments

BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d907 (Published 09 February 2011) Cite this as: BMJ 2011;342:d907
  1. Fiona Godlee, editor, BMJ
  1. fgodlee{at}bmj.com

Two months on from widespread media reports that aspirin reduces deaths from common cancers, are you encouraging your middle aged and older patients to take a daily aspirin? Are you taking one yourself? The reports were based on an impressive meta-analysis published in the Lancet by Peter Rothwell and colleagues (Lancet 2010;376:1741-50). They looked at individual patient data from randomised trials of daily aspirin versus control and found about a 20% reduction in deaths from cancer at five and 20 years.

You may remember that the BMJ’s editorial on the paper was more circumspect (BMJ 2011;342:5-6). In it, Paul Moayyedi …

View Full Text